Understanding Drug Resistance in Tuberculosis Strains in South Africa
Author Information
Author(s): Ioerger Thomas R, Feng Yicheng, Chen Xiaohua, Dobos Karen M, Victor Thomas C, Streicher Elizabeth M, Warren Robin M, Gey van Pittius Nicolaas C, Van Helden Paul D, Sacchettini James C
Primary Institution: Texas A&M University, Colorado State University, Stellenbosch University
Hypothesis
Is drug resistance among Beijing-genotype isolates of Mycobacterium tuberculosis in the Western Cape of South Africa due to clonal transmission?
Conclusion
The study suggests that while MDR-TB is spreading by transmission, further drug resistance is acquired independently.
Supporting Evidence
- 14 drug-resistant clinical isolates were sequenced to understand drug resistance evolution.
- Resistance mutations arose multiple times independently within each cluster of isolates.
- Drug resistance among these isolates appears to be acquired, not clonally derived.
Takeaway
This study looked at how some tuberculosis germs can become resistant to medicine. It found that these resistant germs are not all from the same family but have learned to resist medicine in different ways.
Methodology
Whole-genome sequencing was performed on 14 drug-resistant clinical isolates of the Beijing genotype.
Potential Biases
No intentional sampling bias was applied, but the selection of strains may not represent the entire population of drug-resistant TB.
Limitations
The study's conclusions may not generalize to the broader TB epidemic or other geographic locations due to the limited number of strains sequenced.
Participant Demographics
The isolates were sampled from various hospitals in the Western Cape, South Africa.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website